NCT05594368View on ClinicalTrials.gov

Dose Escalation for SBRT of Recurrent VT Ventricular Tachyarrhythmia - a Single Center, Phase II Clinical Trial

PHASE1RecruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

July 1, 2022

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2028

Conditions
Ventricular Tachycardia
Interventions
DEVICE

Dose escalating stereotactic arrhythmia radioablation to treat ventricular tachycardia (VT)

Dose escalating stereotactic arrhythmia radioablation to treat ventricular tachycardia (VT) refractory to conventional antiarrhythmic and catheter ablation-based therapy. First patients will be treated with a dose from 25 Gy prescribed to the 65-90% target volume encompassing isodose escalating to a maximum of 32.5 Gy prescribed to the 65-90% isodose.

Trial Locations (2)

8091

RECRUITING

University Hospital Zurich, Zurich

Unknown

RECRUITING

University Hospital Ostrava, Ostrava

All Listed Sponsors
lead

University of Zurich

OTHER